间歇性θ爆发刺激联合物理治疗作为帕金森病优化康复方案:随机双盲对照试验研究方案
这是一项随机双盲对照试验方案,计划纳入50例45-70岁Hoehn-Yahr 1-3级的帕金森病患者,随机分为间歇性θ爆发刺激(iTBS)联合物理治疗组与假iTBS联合物理治疗组。试验包括2周双盲治疗期和24周随访期,主要结局为MDS-UPDRS III从基线至住院干预完成后第2天的变化,次要结局为干预后4、12、24周的PDQ-39。作者旨在验证iTBS联合物理治疗较单纯物理治疗能更好改善运动功能与生活质量。
要点
- 研究纳入50例45-70岁、Hoehn-Yahr 1-3级的帕金森病患者,随机分为iTBS联合物理治疗组与假iTBS联合物理治疗组。
- iTBS与假iTBS在物理治疗基础上每日两次、共10天给药,试验含2周双盲治疗期和24周随访期。
- 主要结局为MDS-UPDRS III从基线至住院干预完成后第2天的变化,次要结局为干预后4、12、24周的PDQ-39。
核心结论
- 作者旨在证明iTBS联合物理治疗可促进帕金森病患者整体功能与生活质量,且该疗效可能与运动相关脑区神经可塑性改变有关。
- 作者认为,随着生活质量与运动功能显著改善,iTBS联合物理治疗可考虑作为帕金森病的一线康复选择。
- 作者认为iTBS增强大脑神经可塑性的潜力应对提高物理治疗的普遍性与效率、改善患者生活质量与整体功能状态产生更积极影响。
研究设计与样本
- 研究为随机、双盲、对照临床试验方案,计划纳入50例45-70岁、Hoehn-Yahr量表评分1-3级的帕金森病患者。
- 患者随机分配至iTBS联合物理治疗组或假iTBS联合物理治疗组。
- 试验包括2周双盲治疗期和24周随访期,iTBS与假iTBS在物理治疗基础上每日两次、共10天给药。
关键数值与推荐
- 主要结局为MDS-UPDRS III从基线至住院干预完成后第2天的变化。
- 次要结局为干预后4周、12周和24周的39项帕金森病问卷(PDQ-39)。
- 三级结局包括NMSS、6MWD、10MT、TUG、BBS、MRI和EEG等临床评估与机制研究结局,以及症状波动时需调整药物之间的时间长度。
临床怎么用
- 作者认为,随着生活质量与运动功能显著改善,iTBS联合物理治疗可考虑作为帕金森病的一线康复选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: First-line rehabilitative strategies to improve motor deficits are based on functional training (physical or occupational therapy), which has been demonstrated to facilitate neural reorganisation. Accumulating evidence suggests that non-invasive brain stimulation techniques, such as repetitive TMS (rTMS), may enhance neuroplasticity, thereby facilitating neural reorganisation and recovery from Parkinson's disease. Evidence also shows that intermittent theta-burst stimulation (iTBS) can improve motor function and quality of life in patients by promoting the excitability and neural remodelling of cerebral cortex. We aimed to combine iTBS stimulation with physiotherapy to improve the rehabilitation effect compared to physiotherapy alone in patients with Parkinson's disease. METHODS: This randomised, double-blind clinical trial will enrol 50 Parkinson's disease patients aged 45-70 years with Hoehn and Yahr scale scores of 1-3. Patients are randomly assigned to either the iTBS + physiotherapy or sham-iTBS + physiotherapy group. The trial consists of a 2-week double-blind treatment period and a 24-week follow-up period. iTBS and sham-iTBS will be administered twice daily for 10 days based on physiotherapy. The primary outcome will be the third part of Movement Disorders-Unified Parkinson's Disease Rating Scale (MDS-UPDRS III) from the baseline to the first 2 days following completion hospitalised intervention. The secondary outcome will be 39-item Parkinson's Disease Questionnaire (PDQ-39) at 4 weeks, 12 weeks and 24 weeks after intervention. Tertiary outcomes are clinical evaluations and mechanism study outcomes such as NMSS, 6MWD, 10MT, TUG, BBS, MRI, and EEG, the length of time between the drug needs to be adjusted when symptoms fluctuate. DISCUSSION: The aim of this study is to demonstrate that iTBS can promote overall function and quality of life in Parkinson's disease patients using physiotherapy and that this efficacy may be associated with altered neuroplasticity in exercise-related brain regions. The iTBS combined with physiotherapy training model will be evaluated during a 6-month follow-up period. With significant improvement in quality of life and motor function, iTBS combined with physiotherapy can be considered as a first-line rehabilitation option for Parkinson's disease. The potential of iTBS to enhance neuroplasticity in the brain should have a more positive impact in increasing the generality and efficiency of physiotherapy, improving the quality of life and overall functional status of patients with Parkinson's disease. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2200056581. Registered on 8 February 2022.
引用
- Jin ZH, Wang YX, Meng DT, et al. Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson's disease: study protocol for a randomised, double-blind, controlled trial. Trials. 2023. PMID: 37328845. doi:10.1186/s13063-023-07425-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。